Clinical Trial

Phase I/II Clinical Trial of UX-DA003 Injection for the Treatment of Patients With Parkinson's Disease

Name: Phase I/II Clinical Trial of UX-DA003 Injection for the Treatment of Patients With Parkinson's Disease — clinical trial record (NCT07733349)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This clinical study is designed to explore the safety and tolerability of UX-DA003. It will also explore if UX-DA003 works to improve motor function in subjects with Parkinson's disease.

Trial Details

NCT Number	NCT07733349
Lead Sponsor	Shanghai UniXell Biotechnology Co., Ltd Collaborators: Ruijin Hospital
Conditions	Parkinson's Disease
Enrollment	12 participants
Start Date	2026-08-03
Primary Completion	2029-08-31 (estimated)
Study Completion	2032-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-29